vimarsana.com
Home
Live Updates
DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer : vimarsana.com
DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer
Executive with Strong Track Record in Advancing Pipelines Through Clinical Development
...
Related Keywords
California
,
United States
,
Japan
,
South Korea
,
China
,
Chiron
,
Kyonggi Do
,
American
,
Rick Pauls
,
University Of California
,
Diamedica Therapeutics Inc
,
Yale University
,
Novartis
,
Amgen
,
Nasdaq
,
Opiant Pharmaceuticals
,
Pfenex Inc
,
Marinus Pharmaceuticals Nasdaq
,
Cubist Pharmaceuticals
,
Exchange Commission
,
Diamedica Therapeutics
,
Lorianne Masuoka
,
Chief Medical
,
Chief Executive
,
Chief Medical Officer
,
Epygenix Therapeutics
,
Marinus Pharmaceuticals
,
Nektar Therapeutics
,
Fiveprime Therapeutics
,
American Board
,
Grant Under Nasdaq Listing Rule
,
Inducement Incentive
,
Nasdaq Listing Rule
,
Fast Track Designation
,
Medica Therapeutics
,
Securities Litigation Reform Act
,
Markets
,
vimarsana.com © 2020. All Rights Reserved.